CS Paper Radar

Agentic discovery of blood biomarker from distilled private health records

Seffi Cohen, Liat Antwarg Friedman, Amir Anisman, Ruth Johnson, Michelle M. Li, Ayush Noori, Ben Reis, Ran Balicer, Noa Dagan, Marinka Zitnik

cs.AI ·submitted 2026-10-03 20:30 UTC · v1
code/data

Abstract

Routine complete blood counts (CBCs) could yield new biomarkers, but the private records needed to evaluate candidates cannot be shared with frontier language model agents that excel at discovery. We distilled the evidence held in the Clalit Health Services panel of over 5.4 million patients into a released scoring tool: for each of 13 immune-mediated diseases, a graph attention network was trained inside the data boundary to predict the case-control AUC of candidate CBC expressions, and only the trained weights were released. The tool grounds an agent's propose-score-refine loop in real-world data without exposing any patient data. In external validation, agent-discovered expressions improved on their literature-seeded starting points by a median of 4.18 AUC percentage points, and across three independent cohorts, reranking the candidates of three frontier research tools improved on their first choices in most comparisons, with gains that varied by cohort. The released scorer supports privacy-preserving biomarker hypothesis generation.

Closest papers

Nearest neighbours by meaning across the whole index.

BioStudyBench: Evaluating Agents on Post-Cutoff Biomedical Studies

cs.AI ·2026-10-06 ·David Li, Shaamil Karim, Christian Gensbigler
publishedbenchmark similarity 0.65
Abstract · Accepted into AgenticLS (NeurIPS 2026 workshop)

We evaluate whether AI agents can match the reported findings of published biomedical studies using public data. Existing evaluations do not consistently separate analysis from prior knowledge or retrieval of the published answer. We introduce BioStudyBench, a benchmark of 25 long-horizon analysis tasks drawn from studies first published between July and September 2026, after the developer-reported knowledge cutoffs of the models we evaluate, semi-automatically filtered down from 404,019 PubMed records. In each task, the agent receives a neutral research question but no data files, so it must find and download the relevant public data, search the literature through tools that return only records dated before its cutoff, and report findings through data analysis. To measure gains over prior knowledge, we run every task both with and without access to data and tools. Across eight models, access to data and tools raises the pass rate by 47 percentage points on average over the no-data baseline. Open-weight models across sizes trail closed-weight models, with the best open-weight model passing 81.3% of tasks against 94.7% for the best closed-weight model.

0.25

Ascent: An Agentic System over the Model Context Protocol for Real-World Clinical Data Analysis

cs.AI cs.IR ·2026-09-21 ·Angelo Ziletti, Leonardo D'Ambrosi, Melanie Tuchardt, Tim Kondziella
dataset similarity 0.63
Abstract

Answering epidemiological questions from real-world clinical data requires medical coding, schema-aware SQL, and validation of implicit choices about populations, denominators, and time. We present Ascent, an agentic system that exposes medical coding, question answering, and cohort analysis through a shared Model Context Protocol tool surface for standardized and native schemas. We introduce EpiTrap, a dataset testing whether systems avoid recognized pharmacoepidemiological errors, and compare a fixed pipeline with agents across models and orchestrators. With capable models, agents improve accuracy over the fixed pipeline by an average of 27 and 20 percentage points on native and standardized schemas, respectively. These gains require more tool calls and longer runtimes. Experience from real projects highlights the system's value for feasibility assessment, diagnostic iteration, and expert-guided analysis.

0.06

Role-Specialized Mixture-of-Agents with Open-Weight LLMs for Clinical Prediction

cs.AI cs.LG ·2026-08-23 ·Jun Hou, Yi Fang, Xuan Wang
similarity 0.63
Abstract · COLM 2026 DAIH Workshop

Large Language Models (LLMs) are increasingly applied to clinical prediction tasks such as in-hospital mortality and readmission from electronic health records (EHRs). Privacy and compliance constraints motivate systems that can be deployed locally, which has increased interest in open-weight multi-agent designs. However, most medical multi-agent systems are evaluated as a single block, leaving unclear which agent role contributes to prediction and whether retrieval drives observed gains. We study a role-specialized Mixture-of-Agents (MoA) that combines medical knowledge retrieval with contrastive similar-patient reasoning. By varying the role design while holding the retrieval setup fixed, we localize the main effect to the final integrator. Pairing large open-weight analysts with a small open-weight integrator matches closed-model prompting on F1 for mortality prediction while flagging substantially more true high-risk patients. Mechanism analysis shows the role assignment directly yields a high-recall operating point without threshold tuning. The effect is task-dependent, with smaller gains for readmission because the available records correlate weakly with this longer-horizon outcome. These results position role design as a key factor in privacy-constrained, training-free clinical LLM prediction.

0.26

ClinVerse: A Realistic Multi-Agent Diagnostic Environment for Training and Evaluating Medical Agents

cs.AI cs.MA ·2026-10-26 ·Sirry Chen, Fangke Chen, Xuanwen Ding, Wei Chen, Zhongyu Wei
similarity 0.63
Abstract

Disease diagnosis is a key application of large language model (LLM) agents in healthcare. However, existing medical agents are primarily trained and evaluated with static question-answering data, providing limited opportunities to learn active information acquisition, examination decision-making, and dynamic clinical interaction. To address this limitation, we present ClinVerse, an interactive, real-data-grounded multi-agent environment designed for training and evaluating medical diagnostic agents. Built on ClinPatient, a scalable dataset comprising 150k diagnostic cases derived from real-world electronic health records, ClinVerse supports coordinated interactions among six specialized clinical roles. Specifically, a doctor agent starts from an initial patient complaint, progressively gathers clinical evidence through patient interviews and examination requests, and ultimately produces a diagnosis. For each interaction trajectory, a rule-based scoring framework quantifies information acquisition, examination ordering, and diagnostic accuracy. These trajectory-level scores serve as reward signals for agent training while also enabling scalable evaluation. In experiments, we evaluate various general-purpose and medical-domain models and show that nine self-evolution methods across three categories consistently improve agents' diagnostic capabilities within ClinVerse. We further analyze the interplay among model capability, environment feedback, and self-evolution methods.

0.13

Agentic AI for Healthcare Claim Denial Analysis: A Policy-Grounded Framework for Privacy Preservation

cs.AI cs.LG ·2026-11-06 ·Sofia Campos, Carlos Martins, Pedro Pires, João Gama, Bruno Veloso +1 more
similarity 0.62
Abstract

In the healthcare sector, claim denials impose significant financial and administrative burdens, emphasizing the need for automated and trustworthy decision-support systems. This paper proposes a modular Agentic Artificial Intelligence (AI) framework for healthcare claim denial analysis, integrating specialized agents for denial risk prediction, risk factor identification, diagnosis-procedure-medication code relationship analysis, and counterfactual analysis. The framework integrates predictive analytics, graph-based learning, a Hybrid Contextual Retrieval-Augmented Generation (RAG) pipeline grounded in healthcare policy documents, and a dedicated HIPAA Compliance Agent to support privacy protection. Evaluated on a synthetic healthcare claims dataset, the framework achieved 98% traceability of reported numerical findings, validated 214 of 216 policy citations, and removed all 280 identified sensitive identifiers without modifying the underlying analysis. These findings pave the way for further research into Agentic AI as a framework for explainable, policy-aware, and privacy-preserving healthcare claim denial management.

0.20

Auditing evaluation artifacts and data leakage in large language model systems for rare disease diagnosis

cs.AI ·2026-10-24 ·Jian Yang, Peilin Liu, Xiaohan Li, Songda Li, Yu Cao +2 more
benchmark similarity 0.62
Abstract · 18 page, 3 figures

Augmented large language model (LLM) systems have reported high benchmark accuracies in rare disease diagnosis, yet their real-world clinical utility remains unproven. A recent meta-analysis flagged augmented LLM diagnostic evaluations as having a high risk of bias due to suspected data leakage; however, the precise impact of these vulnerabilities on model inference has yet to be fully quantified. In this study, we present a comprehensive empirical audit to quantify evaluation artifacts across prevailing AI paradigms, using a repository of over 60,000 cases from diverse public and independent clinical cohorts. By reconstructing a state-of-the-art agentic framework, we demonstrate that candidate-space contamination artificially inflates performance: enforcing strict cross-dataset isolation resulted in a marked performance decline, with the cross-dataset mean Recall@1 decreasing from 54.3% (under conventional one-vs-rest evaluation) to 40.3% (Hedges' g = 0.94). Similar spatial overfitting in supervised classifiers caused diagnostic accuracy to drop from an internal mean of 42.9% to 16.7% across external cohorts (Cohen's d = 2.01). Furthermore, we quantify how LLMs infer diagnoses by exploiting retrospective therapeutic cues in clinical narratives, and how temporal misalignment in foundational knowledge bases leads to performance fluctuations. We conclude that prevailing evaluation protocols for augmented LLM systems inadvertently reflect data leakage rather than genuine medical reasoning. To address these systematic artifacts, we propose a rigorous evaluation framework - coupling strict data-isolation protocols with standardized benchmarking safeguards - to ensure future diagnostic AI for rare diseases is evaluated on actual clinical robustness.

0.50

DIASENTINEL: An Auditable Multi-Agent System for Guideline-Grounded Diabetes Risk Screening

cs.CL ·2026-08-31 ·Yung Wei Shueh, Zhi-Jie Chen, Chia-Hsuan Hsu, Hsin-Ling Hsu, Donghua Zhang +7 more
top venue similarity 0.62
Abstract

Large language models (LLMs) offer promising clinical decision support but remain vulnerable to hallucinated facts, unsupported recommendations, and citation errors. We present DIASENTINEL, a fully on-premise multi-agent system for one-year type 2 diabetes mellitus (T2DM) risk screening and guideline-grounded report generation from electronic health records (EHRs). The system integrates calibrated risk prediction, deterministic clinical signal extraction, Reciprocal Rank Fusion over American Diabetes Association (ADA) guidelines, and a hybrid verification layer combining rule-based checks with LLM entailment. The demonstration provides a real-time batch-screening dashboard and an interactive patient report interface with cited recommendations, verification results, and raw EHR comparison. DIASENTINEL demonstrates a practical framework for reliable, auditable, and privacy-preserving LLM-based clinical decision support.

0.33

AI-Driven Reproducibility and Analytical Robustness in Scientific Discovery

cs.AI cs.CL ·2026-10-16 ·Shicheng Liu, Krista Opsahl-Ong, Andrew Drozdov, Julian Killingback, Arnav Singhvi +4 more
benchmark similarity 0.61
Abstract

Reproducible and analytically robust research findings are essential to scientific progress, but evaluating these properties typically requires costly manual effort. We investigate whether LLM agents can help automate reproduction and robustness analysis, using a medical case study grounded in the Surveillance, Epidemiology, and End Results (SEER) database, a widely used U.S. cancer registry underlying tens of thousands of published studies. First, we introduce SEER-Repro, a benchmark of 20 published SEER-based papers together with the data and resources required to reproduce their findings. Second, we create an AI agent that successfully reproduces 77.4% of 2,190 atomic claims, while providing executable baselines for further analysis. Third, we develop an agentic analysis pipeline to test the robustness of the medical findings by identifying analytical choices underlying each finding, proposing defensible alternatives, and rerunning the analysis to determine whether those choices affect the conclusion. Across published papers in SEER-Repro, our pipeline identifies potentially consequential analytical choices in 9.5% of fully reproduced findings and flags them for expert review. These results show how LLM agents can support scientific review by reproducing findings, systematically testing their robustness, and directing expert attention toward potentially consequential analytical choices.

0.22